Literature DB >> 2952061

In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.

J Segreti, H A Kessler, K S Kapell, G M Trenholme.   

Abstract

The in vitro activity of A-56268 (TE-031), a new macrolide antibiotic, against 11 strains of Chlamydia trachomatis was determined and compared with that of four other antibiotics. A-56268 was the most active drug tested. Doxycycline, trimethoprim-sulfamethoxazole, and erythromycin had good activity but were less active in vitro than A-56268.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2952061      PMCID： PMC174660          DOI： 10.1128/AAC.31.1.100

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia.

Authors:  P A Rapoza; T C Quinn; L A Kiessling; W R Green; H R Taylor
Journal:  JAMA       Date:  1986-06-27       Impact factor: 56.272

2.  Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture.

Authors:  C C Kuo; S P Wang; J T Grayston
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

3.  Ultrastructural analysis of the effect of trimethoprim and sulphamethoxazole on the development of Chlamydia trachomatis in cell culture.

Authors:  M R Hammerschlag; J C Vuletin
Journal:  J Antimicrob Chemother       Date:  1985-02       Impact factor: 5.790

4.  In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin.

Authors:  T F Smith; H E Washton
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

5.  Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo.

Authors:  G Johannisson; A Sernryd; E Lycke
Journal:  Sex Transm Dis       Date:  1979 Apr-Jun       Impact factor: 2.830

6.  Comparison of rosaramicin and erythromycin stearate for treatment of cervical infection with Chlamydia trachomatis.

Authors:  H G Robson; P P Shah; R G Lalonde; L Hayes; V M Senikas
Journal:  Sex Transm Dis       Date:  1983 Jul-Sep       Impact factor: 2.830

7.  In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.

Authors:  F W Heessen; H L Muytjens
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

8.  Treatment of chlamydial urethritis in men and Chlamydia trachomatis-positive female partners: comparison of erythromycin and tetracycline in treatment courses of one week.

Authors:  J H Scheibel; J K Kristensen; B Hentzer; L Secher; S Ullman; J Verdich; K Weismann
Journal:  Sex Transm Dis       Date:  1982 Jul-Sep       Impact factor: 2.830

9.  Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.

Authors:  W R Bowie; C K Lee; E R Alexander
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

10.  The antimicrobial susceptibility of Chlamydia trachomatis in cell culture.

Authors:  G L Ridgway; J M Owen; J D Oriel
Journal:  Br J Vener Dis       Date:  1978-04
View more
  16 in total

1.  Comparative in vitro activity of ABT-773, a novel antibacterial ketolide.

Authors:  A M Nilius; M H Bui; L Almer; D Hensey-Rudloff; J Beyer; Z Ma; Y S Or; R K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebae.

Authors:  M Maurin; A Bryskier; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

3.  Antimicrobial susceptibility and serotyping of Chlamydia trachomatis strains isolated before and after treatment with ciprofloxacin and doxycycline.

Authors:  A H van der Willigen; T van Rijsoord-Vos; J H Wagenvoort; W E Stamm; R J Suchland; E Stolz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

Review 4.  New directions for macrolide antibiotics: structural modifications and in vitro activity.

Authors:  H A Kirst; G D Sides
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

5.  In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors:  H Talbot; B Romanowski
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

6.  In vitro activities of temafloxacin (A-62254) and four other antibiotics against Chlamydia trachomatis.

Authors:  J Segreti; H A Kessler; K S Kapell; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

7.  Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis.

Authors:  C Benson; J Segreti; H Kessler; D Hines; L Goodman; R Kaplan; G Trenholme
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

8.  In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone.

Authors:  Angela M Nilius; Linus L Shen; Dena Hensey-Rudloff; Laurel S Almer; Jill M Beyer; Darlene J Balli; Yingna Cai; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

9.  In vitro activity of dirithromycin against Chlamydia trachomatis.

Authors:  J Segreti; K S Kapell
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

10.  Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin.

Authors:  A S Beale; P A Upshon
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.